ease

Release management system for a multi-node application

A deployment system provides the ability to deploy a multi-node distributed application, such as a cloud computing platform application that has a plurality of interconnected nodes performing specialized jobs. The deployment system includes a release management system that builds and manages versioned releases of application services and/or software modules that are executed by the plurality of nodes of the cloud computing platform application. The release management system utilizes specification files to define a jobs and application packages and configurations needed to perform the jobs. The jobs and application packages are assembled into a self-contained release bundle that may be provided to the deployment system. The deployment system unwraps the release bundle and provides each job to deployment agents executing on VMs. The deployment agents apply the jobs to their respective VM (e.g., launching applications), thereby deploying the cloud computing platform application.




ease

Extended release fragrance compositions

Compositions are provided that provide release of fragrance over an extended period of time. The compositions comprise a hydrophilically-modified cross-linked silicone elastomer and an acrylic rheology modifier.




ease

Non-corrosive oven degreaser concentrate

The invention relates to a non-corrosive degreasing concentrate and ready to use formulation. In particular, non-corrosive compositions capable of removing polymerized grease as effectively as some alkali metal hydroxide (i.e. caustic) based degreasers without requiring the use of personal protective equipment are disclosed.




ease

Increased normal zone propagation velocity in superconducting segments

There is described herein a superconducting segment and method of making same comprising one or several layers with very high electrical resistivity, acting as a current flow diverter when the current transfers from the superconductor to the stabilizer. The purpose of this current flow diverter is: i) to increase the contact resistance between the superconductor and the stabilizer, by reducing the contact area, and ii) to force the current to flow along a specific path, so as to increase momentarily the current density in a specific portion of the stabilizer. The consequence of i) and ii) is that heat generated at the extremities of the normal zone is increased and spread over a longer length along the superconducting segment, which increases the NZPV and thus, the uniformity of the quench.




ease

Nitrate esters and their use for the treatment of muscle and muscle related diseases

Alkyl nitrate ester compounds are provided for the delivery of nitric oxide to targeted muscle tissues, and in particular, to normal and dystrophic muscles. In one aspect, nitrate ester compounds are provided having the following formula: wherein, R1 is ONO2, CH2ONO2, CnH2n+1OH, CnH2n+1OH, or CH2CH2CH3, or H;R2 is ONO2, CH2ONO2, Cn'H2n'+1OH, Cn'H2n'+1OH, CH2CH2CH3 or H; andR3 is ONO2, CH2ONO2, Cn'″H2n″+1OH, Cn″H2n″+1OH, CH2CH2CH3 or H; wherein n is an integer from 0 to 9, n' is an integer from 0 to 9, and n″ is an integer from 0 to 9, and n+n'+n″≦9, and wherein at least one of R1, R2, and R3 is an ester nitrate selected from the group consisting of ONO2, CH2ONO2, and combinations thereof.




ease

Hydrocarboxylation of aqueous formaldehyde using a dehydrating recycle stream to decrease water concentration

Disclosed is a process for the production and purification of glycolic acid or glycolic acid derivatives by the carbonylation of aqueous formaldehyde. The water in the hydrocarboxylation zone is reduced via reaction with the ester bonds in a recycle stream comprising glycolic acid oligomers and/or methyl glycolate oligomers.




ease

Tumor and infectious disease therapeutic compositions

A pharmaceutical composition comprising lectins is anti-tumorigenic and anti-viral, bacterial or protozoan. The composition, termed BiOmune is also useful for imaging, diagnosis and therapy of cancer.




ease

Cytosine analogue, a method of preparation of a cytosine analogue, a DNA methyltransferase 1 inhibitor, a method for DNA methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal DNA methylation

A cytosine analog, a method of preparation of a cytosine analog, a DNA methyltransferase 1 inhibitor, and a method for DNA methylation inhibition, is provided for the treatment of diseases associated with deviations from normal DNA methylation. The analog of cytosine may be comprised of 1, N4, 5 and 6-substituted derivatives of cytosine or 5,6-dihydrocytosine, wherein the analog can be described by the chemical formula where R1 is H, R3, R4, 2'-deoxyribosyl, R4 is alkyl or aryl, X is N or C, wherein if X in the analog of formula I is N, then R5 is no substituent and if X in the analog of formula I and/or II is C or if X in the analog of formula II is N, then R5 and R6 are independently alkyl, aryl, hydroxyalkyl, aminoalkyl, hydroxyl, carboxyl, amino group, alkoxyl, aryloxyl, aminoalkyl, aminoaryl, thio group, sulfonyl, sulfinyl or halogen.




ease

Steroids having increased water solubility and resistance against metabolism, and methods for their production

Steroid compounds having increased resistance against metabolism and increased water solubility are disclosed, together with methods for their production. These substances are suitable for the manufacture of pharmaceuticals for the treatment of steroid related or steroid induced CNS disorders and for use in methods of prevention, alleviation or treatment of such disorders.




ease

Dosage form to increase prasterone bioavailability

A way to formulate prasterone to both increase its oral bioavailability, and decrease the variability of its oral bioavailability. In contrast to the approach taught by the prior art, the instant approach is amenable to scale-up to commercial scale. Further, the resulting product is amenable to analysis using standard, known quantitative analytical techniques; thus, unlike the prior art approach, the instant approach may be used to manufacture a product in conformity with applicable regulatory standards.




ease

Delayed-release glucocorticoid treatment of rheumatoid disease

Provided are methods for the treatment of a rheumatic disease, such as rheumatoid arthritis, ankylosating spondylitis and/or polymyalgia rheumatic, by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof wherein the treatment is administered once daily for at least about two weeks. Also provided are methods for the treatment of osteoarthritis by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof wherein the treatment is administered once daily for at least about two weeks.




ease

Treatment of muscle disease characterized by insulin resistance

It is reported herein that certain muscle diseases and conditions, including forms of muscular dystrophy, are characterized by impaired insulin-dependent signaling in the muscle tissue, in essence, a form of insulin resistance. The present disclosure relates to therapeutic agents, compositions and methods for treating a muscle disease or condition characterized by impaired insulin-dependent signaling by targeting components of the defective insulin signaling pathway. The disease or condition may be treated by administering a therapeutic agent that activates the insulin signaling pathway, in particular, therapeutic agents that act post-insulin receptor to modulate intracellular effector molecules. An exemplary modulator is metformin. Metformin may be administered alone or may be coadministered with another therapeutic agent for treating the muscle disease or condition, such as a corticosteroid.




ease

Molecules that induce disease resistance and improve growth in plants

Described herein are methods and compositions for enhancing pathogen immunity in plants and improving plant growth.




ease

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

The methods described herein enable the evaluation of compounds on subjects to assess their therapeutic efficacy or toxic effects. The target of analysis is the underlying biochemical process or processes (i.e., metabolic process) thought to be involved in disease pathogenesis. Molecular flux rates within the one or more biochemical processes serve as biomarkers and are quantitated and compared with the molecular flux rates (i.e., biomarker) from control subjects (i.e., subjects not exposed to the compounds). Any change in the biomarker in the subject relative to the biomarker in the control subject provides information to evaluate therapeutic efficacy of an administered drug or a toxic effect and to develop the compound further if desired. In one aspect of the invention, stable isotope-labeled substrate molecules are administered to a subject and the label is incorporated into targeted molecules in a manner that reveals molecular flux rates through metabolic pathways of interest.




ease

Device and method for delivering mechanically released cells from liposuction aspirates

A lipoaspirate collection device to aid in the collection and processing of human tissue and fluid obtained during liposuction for use in point-of-care cell therapy. The collection device includes a collection body and a collection cap. The collection cap may have a fluid port, a lipoaspirate port, a vacuum port, and a relief valve. Within the central cavity of the collection device, a cone shaped may be positioned such that the apex of the cone is positioned underneath the lipoaspirate inlet through which the lipoaspirate fluid and tissue are introduced.




ease

Thermal image receiver elements having release agents

A thermal image receiver element dry image receiving layer has a Tg of at least 25° C. and is the outermost layer. The dry image receiving layer has a dry thickness of at least 0.5 μm and up to and including 5 μm. It comprises a water-dispersible release agent and a polymer binder matrix that consists essentially of: (1) a water-dispersible acrylic polymer comprising chemically reacted or chemically non-reacted hydroxyl, phospho, phosphonate, sulfo, sulfonate, carboxy, or carboxylate groups, and (2) a water-dispersible polyester that has a Tg of 30° C. or less. The water-dispersible acrylic polymer is present in an amount of at least 55 weight % and at a dry ratio to the water-dispersible polyester of at least 1:1. The thermal image receiver element can be used to prepare thermal dye images after thermal transfer from a thermal donor element.




ease

Dual cure method for ink for increased durability and adhesion to golf balls

A method is disclosed for curing ink printed images on golf balls by printing an image onto a golf ball and exposing the printed image to infrared radiation, then exposing the printed image to ultraviolet radiation.




ease

Autonomous intracardiac implantable medical device with releaseable base and fastener element

An intracorporeal autonomous active medical device having a capsule body and a base. The capsule body includes a body portion and a lid portion, and the capsule body contains therein electronic circuitry containing the active elements of the autonomous medical device, and a power supply. The capsule body also includes a fastening system on an exterior surface of the capsule body that is configured to correspond with a fastening mechanism on the base configured to be anchored to a tissue wall. The fastening mechanism provides selective engagement between the capsule body and the base.




ease

Skull-focused RF-based stimulation apparatus, system and method for treating patients with Alzheimer's disease or other dementia

The portable, wearable, proximal Alzheimer's disease treatment invention is based upon creating an RF field of particular frequencies and intensities that are applied to the patient's head. To accomplish the aforementioned disease treatment functionality, a system was invented comprising a network of antennas connected to an RF generator via a feedline connector. The invention also provides methods for using measurements to monitor and manage the effectiveness of an ongoing disease treatment regimen, and databases which contain information about measurements, variables, and their relationships to clinical outcome.




ease

Quick-release cymeal mounting fastener

A fastener for quick-mounting a cymbal to an upright cymbal support rod comprising a pair of half-round sleeve members arranged in face-to-face relationship forming a cylindrical surface therebetween for grasping the cymbal mounting rod; a tab extending upward from each sleeve member including means for pivoting said members near said tabs so that, by squeezing said tabs together, said sleeve members are pivoted away from each other; a pair of split flange members, one attached to the lower end of each sleeve member, spaced apart from said tab, arranged in co-planar alignment when said members are in adjacent contact to form a planar compression surface for pressing toward a cymbal placed on the cymbal mounting rod; and, means for biasing said sleeve members into full contact about the cymbal mounting rod threaded end to hold the cymbal on the rod.




ease

Modalities for the treatment of degenerative diseases of the retina

This invention relates to methods for improved cell-based therapies for retinal degeneration and for differentiating human embryonic stem cells and human embryo-derived into retinal pigment epithelium (RPE) cells and other retinal progenitor cells.




ease

Nonhuman mammal whose mtDNA is from a nonhuman mammal resistant to a selected disease or disorder and whose nDNA is from a nonhuman donor mammal more susceptible to the selected disease or disorder

Provided herein are mitochondrial-nuclear exchanged cells and animals comprising mitochondrial DNA (mtDNA) from one subject and nuclear DNA (nDNA) from a different subject. Methods for producing a mitochondrial-nuclear exchanged animal and animals made by the methods are provided. Also provided are methods of screening for agents useful for treating a disease or disorder using mitochondrial-nuclear exchanged animals or cells, tissues or organs thereof.




ease

BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.




ease

Method of preparing greases

Provided is a method for preparing a grease composition, which comprises mixing an amine in a lubricating bas oil and an isocyanate in a lubricating base oil under high pressure and high flow rate impingement. In one embodiment, the mixing and reaction occurs in a reaction injection molding device. The resulting grease composition is an extremely low noise grease, being virtually clear of any urea thickener particles.




ease

Grease composition for hub unit bearing employing an angular contact ball bearing and hub unit bearing

The invention provides a grease composition for a hub unit bearing employing an angular contact ball bearing, containing (a) as a thickener a mixture of diurea compounds represented by formula (I): R1—NHCONH—R2—NHCONH—R1, formula (II): R1—NHCONH—R2—NHCONH—R3, and formula (III): R3—NHCONH—R2—NHCONH—R3 wherein R1 is cyclohexyl group, R2 is a divalent aromatic hydrocarbon group having 6 to 15 carbon atoms, R3 is a straight-chain or branched alkyl group having 12 to 20 carbon atoms, and (R1/(R1+R3))×100=85 to 95 mol %; (b) a base oil; (c) a molybdenum dialkyldithiocarbamate; and (d) a calcium sulfonate. The grease composition of the invention, when used in the hub unit bearing, shows minimum leakage, excellent anti-flaking properties and satisfactory bearing lubrication life.




ease

Thickened grease composition

A thickened grease composition is provided by process of heating a mineral oil and 12-hydroxystearic acid with lithium hydroxide and forming a simple lithium grease to which at least one component selected from the group comprising succinic acid, glutaric acid, adipic acid, 6-hydroxycaproic acid, dimethyl succinate, dimethyl glutarate, dimethyl adipate, methyl hydroxycaproate, cyclohexanediols, methyl 5-hydroxyvalerate, methyl valerate, gamma butyrolactone, and methyl levulinate or mixtures thereof.




ease

Recyclable ring binder apparatus with quick release ring metals

A recyclable ring binder apparatus comprises a ring metal incorporating a set of binder rings that are formed of a pair of ring halves. The ring metal can be firmly fastened to a spine section of a binder hardcover by utilizing a post and a small arched snap clamp with a tap. The tap of the snap clamp can be pressed around a neck of the post utilizing a quick release clipping mechanism. The snap clamp can be accessed with an index finger and slid away from the post to remove the ring metal from the hardcover. The ring metal, the hardcover, the snap clamp and the post can be quickly separated into their perspective categories due to the clipping mechanism. Hence, it retains conformance of all components of the ring binder apparatus for recycling without increasing development and production cost.




ease

Refillable notebook with release mechanism

A binding mechanism assembly for binding a sheet item, the binding mechanism assembly including a backing member having an upper surface, and a binding member directly or indirectly coupled to the backing member. The binding member includes a protrusion shaped and located to protrude through a hole of a sheet item to be bound thereto. The binding member further includes a generally flexible flange that is manually movable into engagement with the protrusion to form a generally closed loop and thereby bind the sheet item thereto. The loop is rotatable relative to the backing member from a first position in which the loop is generally located above the upper surface to a second position wherein at least part of the loop is located below the upper surface. A release mechanism is provided for opening the loop.




ease

Increased spectral efficiency and reduced synchronization delay with bundled transmissions

Techniques are provided for increasing spectral efficiency over data channels in a storage or communication system. In some embodiments, data may be encoded and transmitted over multiple channels. The transmitted data from the multiple channels may be considered together as a channel bundle, thereby increasing the edge transitions of the group of signals to improve clock recovery and reduce coding constraints. In some embodiments, the channel bit size is reduced to maximize data rates based on the reduced coding constraints. Furthermore, the channel bundle has only one channel with timing markers, so that a receiver may receive information from the channel bundle and recover clocking based on the timing markers in the one channel.




ease

Patch having easily detachable release sheet

A patch permitting division of only its release sheet by simply pulling right and left, wherein detachment of the release sheet is easy. There is provided a patch comprising a stretchable support, a plaster applied substantially all over one major surface of the support and a release sheet attached to the whole surface of the plaster wherein only the release sheet is divided at a division zone by simply pulling right and left, and wherein one or two or more precut parts that open when the patch is pulled right and left are disposed in the neighborhood on the division zone.




ease

Hydrogel tissue adhesive having decreased gelation time and decreased degradation time

A hydrogel tissue adhesive having decreased gelation time and decreased degradation time is described. The hydrogel tissue adhesive is formed by reacting an oxidized polysaccharide containing aldehyde groups with a water-dispersible, multi-arm amine in the presence of a thiol additive. The thiol additive accelerates the process to form the hydrogel and accelerates the degradation of the hydrogel formed. The hydrogel may be useful as a tissue adhesive or sealant for medical applications, such as a hemostat sealant or to prevent undesired tissue-to-tissue adhesions resulting from trauma or surgery.




ease

Universal linker compositions for the release or transfer of chemical agents from a polynucleotide

A universal linker structure is provided, in which a functional group and activating leaving group are placed on a tether, allowing the placement of an electrophile at the end of any nucleic acid sequence. The electrophile on the tether can react with a second nucleic acid carrying a nucleophile when the two nucleic acids are hybridized near one another, resulting in release of the leaving group, and creation of a functional change. The linker can be designed to destabilize the ligation product without slowing the rate of reaction. This lowers product inhibition, and the target DNA or RNA can become a catalyst for isothermally generating multiple signals for detection. This enhanced signal is demonstrated in solution experiments and in solid supported assays. The universal linkers of the present invention are simple and inexpensive to prepare, and can be appended to any polynucleotide in automated steps on a standard DNA synthesizer.




ease

Polypeptides with permease activity

The invention relates to a polypeptide having a mutation at one or more position corresponding to T219 of SEQ ID NO: 55, wherein the polypeptide has at least 50% sequence identity with SEQ ID NO: 55, and wherein the polypeptide has permease activity.




ease

Methods for treating steatotic disease

Methods for treating fatty liver disease, e.g., hepatic steatosis, using peptide fragments of the C-terminal end of glucagon-like peptide-1 (GLP-1), e.g., GLP-1(28-36).




ease

Method for the treatment of automimmune diseases comprising administering rapamycin and IL-10

The invention discloses a combined preparation containing IL-10 and rapamycin, able to induce immunosuppression and antigen-specific immune tolerance, and the use thereof in the treatment of diseases involving an excessive, dysfunctional or uncontrolled immune responses mediated by T cells.




ease

Double function, hand operated meat tenderizer with quick release clip

A double function, hand operated meat tenderizer includes a handle with a blade segment clamped inside said handle; a generally flat plate attached to said handle by at least one slidably moving cylinder attached to a compressed spring, comprising at least one seat including a releasably attached spigot of the cylinder, wherein an end face of said plate is provided with a plurality of projections and flow-through slots aligned in evenly spaced relation, parallel to the spring axis, and wherein in a position of rest, ends of said blades are retracted in said flow-through slots.




ease

Method for removing blood released during filleting from the backbone of fish, and device for removing such blood

In a method for removing blood released during filleting from the backbone and the indentations therein in the region of the vertebrae of fish that are conveyed in a row with the head forwards and the belly downwards, the removal of blood is carried out at the same time and in the same place as the cutting of the backbone. The backbone, which is freed of ray bones and rib bones, is guided through a cutting gap and is cut clear on the belly side of the fish over the entire length of the fish as far as the root of the dorsal fin to leave a backbone stump. The fish fillet flesh is covered by covering surfaces which converge at the cutting gap and of which at least two covering surfaces form the cutting gap. Pressurized cleaning fluid is sprayed onto the backbone that is guided between the covering surfaces through the cutting gap during cutting. A device for removing said released blood comprises a backbone cutting device having two backbone cutting circular blades, which are arranged obliquely in an inverted V shape and form the covering surfaces, and having fish guiding means forming covering surfaces that cover the fish fillet flesh. A cleaning device comprises at least one cleaning nozzle aligned with the cutting gap. An actuating device actuates the cleaning device and the backbone cutting device simultaneously. The covering surfaces protect the fish fillet flesh from being sprayed with the cleaning fluid.




ease

Method of detecting pancreatic disease and pancreas testing kit

A pancreatic disease is tested for with high sensitivity even with simple equipment and a simple procedure. Provided is a method of detecting pancreatic disease including detecting a concentration of S100P in at least one of a pancreatic juice and a body fluid containing pancreatic juice collected from a test subject by immunochromatography. Additionally provided is a pancreas testing kit including an immunochromatography device that holds an anti-S100P antibody and a collection vessel that retains a protease inhibitor that inhibits an activity of a protease contained in the pancreatic juice.




ease

Circular stapler with increased lumen diameter

A surgical stapling device is provided having a shell assembly including an outer housing portion having areas of varying wall thicknesses. Individual staple pockets in a row of staple pockets are positioned in areas of thinner wall thicknesses. Areas of increased wall thicknesses form longitudinally extending strengthening ribs along an inner surface of the outer housing portion. The longitudinally extending strengthening ribs may be solid, indented in the wall of the outer housing portion and or bisected by a slot extending through the outer housing portion.




ease

System and method for restraining a vehicle with a collision release mechanism

A vehicle restraint system includes a strap assembly configured to be positioned on a portion of a tire of a vehicle to secure the vehicle to a deck of a transport. The strap assembly is also configured to be coupled to the deck of the transport on a first side of the tire of the vehicle. The system also includes a mandrel assembly operable to be coupled to the strap assembly on a second side of the tire of the vehicle, opposite the first side. The system further includes a winch assembly configured to be coupled to the deck of the transport and the mandrel assembly on the second side of the tire of the vehicle, the winch assembly configured to rotate the mandrel assembly to produce a tightening force to tighten the strap assembly around the portion of the tire. The system still further includes a release mechanism disposed between the winch assembly and the mandrel assembly and configured to create a coupling between the winch assembly and the mandrel assembly in a manner that transmits the tightening force from the winch assembly to the mandrel assembly. The release mechanism is configured to release the coupling between the winch assembly and the mandrel assembly when a force greater than or equal to a predetermined force is produced against the release mechanism.




ease

Method to increase I/O density and reduce layer counts in BBUL packages

An apparatus including a die including a dielectric material on a device side, an insulating layer surrounding a die area and embedding a thickness dimension of the die; and a carrier including a plurality of layers of conductive material disposed on the device side of the die, a first one of the layers of conductive materials being formed on the insulating layer and patterned into traces at least a portion of which are connected to respective contact points on the die. A method including disposing a die on a sacrificial substrate with a device side of the die opposite the sacrificial substrate; disposing a mold on the sacrificial substrate around; introducing an insulating material into a chase of the mold; removing the mold; forming a carrier on the insulating material adjacent a device side of a die; and separating the die and the carrier from the sacrificial substrate.




ease

Recombinant DNA constructs encoding ribonuclease cleavage blockers and methods for modulating expression of a target gene

This invention provides recombinant DNA constructs and methods for manipulating expression of a target gene that is regulated by a small RNA, by interfering with the binding of the small RNA to its target gene. More specifically, this invention discloses recombinant DNA constructs encoding cleavage blockers, 5-modified cleavage blockers, and translational inhibitors useful for modulating expression of a target gene and methods for their use. Further disclosed are miRNA targets useful for designing recombinant DNA constructs including miRNA-unresponsive transgenes, miRNA decoys, cleavage blockers, 5-modified cleavage blockers, and translational inhibitors, as well as methods for their use, and transgenic eukaryotic cells and organisms containing such constructs.




ease

Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-spondins) and/or Wnt

The present invention relates to a composition useful for the diagnosis of diseases associated with aberrant expression of the genes encoding the secreted proteins Futrin 1, 2, 3 and/or 4(=R-Spondin 2, 3, 1 and 4, respectively), e.g. in connection with tumors or diseases of the muscle, kidneys or bones. The present invention also relates to a pharmaceutical composition containing a compound which is capable of modifying (a) the expression of the gene encoding Futrin 1, 2, 3 and/or 4 or (b) the activity of the Futrin 1, 2, 3 and/or 4 protein.




ease

Vacuum nozzle having back-pressure release hole

A pick-and-place vacuum nozzle including a a nozzle body, a vacuum chamber within the nozzle body, a cavity formed in a lower surface of the nozzle body below the vacuum chamber, wherein the cavity is shaped to hold a head gimbal assembly, a back pressure relief hole passing through the nozzle body and connected to the vacuum chamber, the back pressure relief hole communicating with an exterior of the nozzle body, wherein a diameter of the back pressure relief hole is between 0.5 mm and 1 mm. The backpressure relief hole prevents light parts from sticking to the nozzle tip after vacuum is no longer applied.




ease

Anti-theft security device to increase marketing opportunities

The present invention relates to a security device for improving the marketing impact of an article of commerce. The device generally includes a housing having a base and a cover with the cover having at least one opening to allow for the insertion of an attachment mechanism. The housing element of the present invention in one embodiment is in a shape representing a particular theme such as a particular trademark, trade dress, special events, commemorative events, historical events and combinations thereof. The housing may contain an RFID device and/or an electronic article security device. The present invention also provides a method of attaching a security device described herein to an article of commerce.




ease

Release preventing system for wall cupboards

A release-preventing system for wall cupboards wherein a cupboard (40, 70, 105, 110, 150) is hooked to a support (47, 76, 97, 115, 155) fixed to the wall (48, 77, 98, 114, 154) by a hook (41, 73, 91, 125, 162) of a cupboard holding device (40, 90, 124, 163) characterized in that between the hook (41, 73, 91, 125, 162) and the support (47, 76, 97, 115, 155) there is a release preventing element (51, 79, 101, 121, 160, 167) that prevents unhooking of the cupboard.




ease

System and methods for detecting liver disease

A noninvasive, quantitative imaging technique is presented for detecting and diagnosing liver disease, such as cirrhosis. The technique includes: capturing scan data from a subject using computed tomography or another type of imaging method and extracting image data representing the liver from the scan data. Various measures of the liver may be obtained from image data and then used to compute random variables of a statistical model, where the model is predictive of a medical condition of the liver and comprised of random variables that are indicative of at least one of a shape or texture of the liver. Output from the statistical model provides an indication of an undesirable condition of the liver.




ease

Unreleased mems resonator and method of forming same

A microelectromechanical (MEM) resonator includes a resonant cavity disposed in a first layer of a first solid material disposed on a substrate and a first plurality of reflectors disposed in the first layer in a first direction with respect to the resonant cavity and to each other. Each of the first plurality of reflectors comprises an outer layer of a second solid material and an inner layer of a third solid material. The inner layer of each of the first plurality of reflectors is adjacent in the first direction to the outer layer of each reflector and to either the outer layer of an adjacent reflector or the resonant cavity.




ease

Enhanced electrical shocking device with improved long life and increased power circuitry

An improved stun-gun or electrical shock device which includes improved circuit elements to eliminate the frequent product failure due to corrosion and pitting of an internal spark gap as found in prior art electrical shocking devices. The conventional internal spark gap found in prior art stun-guns is replaced with a pair of surge arrestors, thereby eliminating the problems caused by corrosion and pitting of the internal spark gap which has caused prior art stun-guns to have a limited life and fail.




ease

Partition providing increased legroom

A partition for separating front and rear occupant areas of a vehicle comprises a frame and multiple panel members. The frame is attached to the vehicle and has an upper lateral member, respective angled side tubular members and a window. The multiple panel members are configured to fit vertically between the window and a floor pan and horizontally between first and second sides. The multiple panel members comprise a first panel member for positioning adjacent the first side, a second panel member for positioning adjacent the second side and a center section laterally adjacent and separating the first and second panel members. The center section protrudes rearwardly relative to the first panel member and the second panel member. The second panel member is recessed forwardly of the first panel member and forwardly of the center section to increase space available in a rear seat aligned with the second panel member.